Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the XVI dual registration tool for image-guided radiotherapy in prostate cancer.
Sousa F, Jourani Y, Van den Begin R, Otte FX, Ridai S, Desle M, Ferreira A, Ahmimed R, van Klink-de Goeij MCM, Van Gestel D. Sousa F, et al. Among authors: van gestel d, van den begin r, van klink de goeij mcm. Tech Innov Patient Support Radiat Oncol. 2021 Apr 20;18:22-28. doi: 10.1016/j.tipsro.2021.03.003. eCollection 2021 Jun. Tech Innov Patient Support Radiat Oncol. 2021. PMID: 33997323 Free PMC article.
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.
Spaas M, Sundahl N, Hulstaert E, Kruse V, Rottey S, De Maeseneer D, Surmont V, Meireson A, Brochez L, Reynders D, Goetghebeur E, Van den Begin R, Van Gestel D, Renard V, Dirix P, Mestdagh P, Ost P. Spaas M, et al. Among authors: van gestel d, van den begin r. BMC Cancer. 2021 May 7;21(1):514. doi: 10.1186/s12885-021-08088-w. BMC Cancer. 2021. PMID: 33962592 Free PMC article.
Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact.
Artigas C, Diamand R, Shagera QA, Plouznikoff N, Fokoue F, Otte FX, Gil T, Peltier A, Van Gestel D, Flamen P. Artigas C, et al. Among authors: van gestel d. Cancers (Basel). 2021 Oct 4;13(19):4982. doi: 10.3390/cancers13194982. Cancers (Basel). 2021. PMID: 34638466 Free PMC article.
Lymphocyte-sparing pelvic radiotherapy for prostate cancer: An in-silico study.
Baré M, Poeta S, Fernandes P, Jourani Y, Otte FX, Van Brussel S, Van Gestel D, Van den Begin R. Baré M, et al. Among authors: van gestel d, van brussel s, van den begin r. Phys Imaging Radiat Oncol. 2022 Jul 30;23:127-133. doi: 10.1016/j.phro.2022.07.006. eCollection 2022 Jul. Phys Imaging Radiat Oncol. 2022. PMID: 35941862 Free PMC article.
80 results